COYA: Coya Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 97.91
Enterprise Value ($M) 66.85
Book Value ($M) 32.01
Book Value / Share 1.92
Price / Book 3.06
NCAV ($M) 31.96
NCAV / Share 1.91
Price / NCAV 3.06

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.30

Liquidity (mrq)
Quick Ratio 15.31
Current Ratio 15.31

Balance Sheet (mrq) ($M)
Current Assets 35.51
Assets 35.55
Liabilities 3.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-12 13G/A Vanguard Group Inc 5.55 0.00
02-14 13G/A Greenlight Capital Inc 8.80 -0.39
02-07 13G/A Hirschman Orin 8.10 68.17

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 7,239 57,781 12.53
2025-01-30 1,283 32,500 3.95
2025-01-29 3,476 42,207 8.24
2025-01-28 2,123 36,335 5.84
2025-01-27 5,739 39,317 14.60

(click for more detail)

Similar Companies
COCP – Cocrystal Pharma, Inc. COEP – Coeptis Therapeutics Holdings, Inc.
CORT – Corcept Therapeutics Incorporated CPRX – Catalyst Pharmaceuticals, Inc.
CRBP – Corbus Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io